QR kód

SARS-CoV-2 Variants: A Synopsis of In Vitro Efficacy Data of Convalescent Plasma, Currently Marketed Vaccines, and Monoclonal Antibodies

We summarize here in vitro evidences of efficacy for convalescent plasma, currently approved vaccines and monoclonal antibodies against SARS-CoV-2 variants of concern (VOC: B.1.1.7, B.1.351, P.1, and B.1.617.2), variants of interest (VOI: B.1.427/B.1.429, P.2, B.1.525, P.3, B.1.526, and B.1.671.1),...

Celý popis

Uloženo v:
Hlavní autoři: Daniele Focosi, Marco Tuccori, Andreina Baj, Fabrizio Maggi
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI AG 2021-06-01
Edice:Viruses
Témata:
COVID-19
SARS-CoV-2
convalescent plasma
neutralizing antibody
immune escape
mutations
On-line přístup:https://www.mdpi.com/1999-4915/13/7/1211
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky